Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Mesa Laboratories, Inc. (MLAB : NSDQ)

• Company Description    MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy. Number of Employees: 717

• Price / Volume Information    Yesterday's Closing Price: $127.78 Daily Weekly Monthly 20 Day Moving Average: 164,386 shares Shares Outstanding: 5.60 (millions) Market Capitalization: $715.04 (millions) Beta: 0.97 52 Week High: $132.70 52 Week Low: $58.83 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 25.74% 26.31% 12 Week 22.77% 20.16% Year To Date 62.78% 44.36%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 12100 W 6TH AVE - LAKEWOOD,CO 80228 USA ph: 303-987-8000 fax: 303-987-8989 investorrelations@mesalabs.com http://www.mesalabs.com

• General Corporate Information    Officers Siddhartha Kadia - Chief Executive Officer; President; and Director John Sullivan - Chairman of the Board of Directors John Sakys - Chief Financial Officer and Chief Accounting Offic JenniferAlltoft - Director Mark Capone - Director Peer Information Mesa Laboratories, Inc. (ABMD) Mesa Laboratories, Inc. (DMDS) Mesa Laboratories, Inc. (CPWY.) Mesa Laboratories, Inc. (EQUR) Mesa Laboratories, Inc. (ECIA) Mesa Laboratories, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 59064R109 SIC: 3823 Fiscal Year Fiscal Year End: March Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/05/26 Share - Related Items Shares Outstanding: 5.60 Most Recent Split Date: (:1) Beta: 0.97 Market Capitalization: $715.04 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.50% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.64 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.09 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: -0.02 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 08/31/2026 - $0.16 Next EPS Report Date: 11/05/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 17.22 PEG Ratio: - Price Ratios Price/Book: 3.79 Price/Cash Flow: 10.85 Price / Sales: 2.86 EPS Growth vs. Year Ago Period: 36.42% vs. Previous Quarter: 44.44% Sales Growth vs. Year Ago Period: 1.00% vs. Previous Quarter: -5.63% ROE 06/30/26 - 22.72 03/31/26 - 20.96 12/31/25 - 22.02 ROA 06/30/26 - 9.82 03/31/26 - 8.78 12/31/25 - 8.86 Current Ratio 06/30/26 - 1.79 03/31/26 - 1.72 12/31/25 - 1.94 Quick Ratio 06/30/26 - 1.32 03/31/26 - 1.29 12/31/25 - 1.45 Operating Margin 06/30/26 - 16.83 03/31/26 - 15.23 12/31/25 - 15.51 Net Margin 06/30/26 - 1.92 03/31/26 - 2.69 12/31/25 - 1.51 Pre-Tax Margin 06/30/26 - 3.75 03/31/26 - 4.82 12/31/25 - 5.68 Book Value 06/30/26 - 33.73 03/31/26 - 33.71 12/31/25 - 33.81 Inventory Turnover 06/30/26 - 3.31 03/31/26 - 3.34 12/31/25 - 3.45 Debt-to-Equity 06/30/26 - 0.73 03/31/26 - 0.78 12/31/25 - 0.86 Debt-to-Capital 06/30/26 - 42.10 03/31/26 - 43.92 12/31/25 - 46.30

Powered by Zacks Investment Research ©